↓ Skip to main content

Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era

Overview of attention for article published in Stem Cell Research & Therapy, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
100 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Published in
Stem Cell Research & Therapy, May 2021
DOI 10.1186/s13287-021-02334-5
Pubmed ID
Authors

Birbal Singh, Gorakh Mal, Vinod Verma, Ruchi Tiwari, Muhammad Imran Khan, Ranjan K. Mohapatra, Saikat Mitra, Salem A. Alyami, Talha Bin Emran, Kuldeep Dhama, Mohammad Ali Moni

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 100 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 12%
Researcher 7 7%
Student > Master 6 6%
Student > Postgraduate 5 5%
Other 4 4%
Other 11 11%
Unknown 55 55%
Readers by discipline Count As %
Medicine and Dentistry 12 12%
Biochemistry, Genetics and Molecular Biology 10 10%
Nursing and Health Professions 5 5%
Agricultural and Biological Sciences 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 9 9%
Unknown 54 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2021.
All research outputs
#15,813,952
of 24,273,038 outputs
Outputs from Stem Cell Research & Therapy
#1,301
of 2,580 outputs
Outputs of similar age
#245,375
of 432,027 outputs
Outputs of similar age from Stem Cell Research & Therapy
#39
of 102 outputs
Altmetric has tracked 24,273,038 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,580 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,027 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.